92
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Circulating and exhaled vascular endothelial growth factor in asthmatic pregnancy

, , , , , , , , & show all
Pages 648-654 | Received 22 Apr 2012, Accepted 13 Jul 2012, Published online: 20 Aug 2012

References

  • Asai K, Kanazawa H, Kamoi H, Shiraishi S, Hirata K, Yoshikawa J. (2003). Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy 33:595–599.
  • Asai K, Kanazawa H, Otani K, Shiraishi S, Hirata K, Yoshikawa J. (2002). Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects. J Allergy Clin Immunol 110:571–575.
  • Banks RE, Forbes MA, Searles J, Pappin D, Canas B, Rahman D, Kaufmann S, Walters CE, Jackson A, Eves P, Linton G, Keen J, Walker JJ, Selby PJ. (1998). Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1. Mol Hum Reprod 4:377–386.
  • Belanger K, Hellenbrand ME, Holford TR, Bracken M. (2010). Effect of pregnancy on maternal asthma symptoms and medication use. Obstet Gynecol 115:559–567.
  • Bikov A, Pako J, Kovacs D, Tamasi L, Lazar Z, Rigo J, Losonczy G, Horvath I. (2011). Exhaled breath volatile alterations in pregnancy assessed with electronic nose. Biomarkers 16:476–484.
  • Bohács A, Pállinger E, Tamási L, Rigó J Jr, Komlósi Z, Müller V, Dong Y, Magyar P, Falus A, Losonczy G. (2010). Surface markers of lymphocyte activation in pregnant asthmatics. Inflamm Res 59:63–70.
  • Charan NB, Baile EM, Paré PD. (1997). Bronchial vascular congestion and angiogenesis. Eur Respir J 10:1173–1180.
  • Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, Lammoglia R, Charnock-Jones DS. (1998). A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 59:1540–1548.
  • Corne J, Chupp G, Lee CG, Homer RJ, Zhu Z, Chen Q, Ma B, Du Y, Roux F, McArdle J, Waxman AB, Elias JA. (2000). IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest 106:783–791.
  • Dalaveris E, Kerenidi T, Katsabeki-Katsafli A, Kiropoulos T, Tanou K, Gourgoulianis KI, Kostikas K. (2009). VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Lung Cancer 64:219–225.
  • Dombrowski MP. (2006). Asthma and pregnancy. Obstet Gynecol 108:667–681.
  • Espinoza J, Uckele JE, Starr RA, Seubert DE, Espinoza AF, Berry SM. (2010). Angiogenic imbalances: the obstetric perspective. Am J Obstet Gynecol 203:17.e1–17.e8.
  • Feltis BN, Wignarajah D, Zheng L, Ward C, Reid D, Harding R, Walters EH. (2006). Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. Am J Respir Crit Care Med 173:1201–1207.
  • Font-Ribera L, Kogevinas M, Zock JP, Gómez FP, Barreiro E, Nieuwenhuijsen MJ, Fernandez P, Lourencetti C, Pérez-Olabarría M, Bustamante M, Marcos R, Grimalt JO, Villanueva CM. (2010). Short-term changes in respiratory biomarkers after swimming in a chlorinated pool. Environ Health Perspect 118:1538–1544.
  • Gessner C, Rechner B, Hammerschmidt S, Kuhn H, Hoheisel G, Sack U, Ruschpler P, Wirtz H. (2010). Angiogenic markers in breath condensate identify non-small cell lung cancer. Lung Cancer 68:177–184.
  • Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2009. www.ginasthma.com (Accessed 20 August 2011).
  • Horváth I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, Becher G, van Beurden WJ, Corradi M, Dekhuijzen R, Dweik RA, Dwyer T, Effros R, Erzurum S, Gaston B, Gessner C, Greening A, Ho LP, Hohlfeld J, Jöbsis Q, Laskowski D, Loukides S, Marlin D, Montuschi P, Olin AC, Redington AE, Reinhold P, van Rensen EL, Rubinstein I, Silkoff P, Toren K, Vass G, Vogelberg C, Wirtz H; ATS/ERS Task Force on Exhaled Breath Condensate. (2005). Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26:523–548.
  • Hoshino M, Nakamura Y, Hamid QA. (2001a). Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 107:1034–1038.
  • Hoshino M, Takahashi M, Aoike N. (2001b). Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 107:295–301.
  • Jelkmann W. (2001). Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 47:617–623.
  • Kanazawa H, Asai K, Hirata K, Yoshikawa J. (2002a). Vascular involvement in exercise-induced airway narrowing in patients with bronchial asthma. Chest 122:166–170.
  • Kanazawa H, Hirata K, Yoshikawa J. (2002b). Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients. Thorax 57:885–888.
  • Kastelijn EA, Rijkers GT, Van Moorsel CH, Zanen P, Kwakkel-van Erp JM, Van De Graaf EA, Van Kessel DA, Grutters JC, Van Den Bosch JM. (2010). Systemic and exhaled cytokine and chemokine profiles are associated with the development of bronchiolitis obliterans syndrome. J Heart Lung Transplant 29:997–1008.
  • Kharb S. (2009). Serum markers in pre-eclampsia. Biomarkers 14:395–400.
  • Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, Kang MJ, Cohn L, Kim YK, McDonald DM, Elias JA. (2004). Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 10:1095–1103.
  • Lee KY, Lee KS, Park SJ, Kim SR, Min KH, Choe YH, Lee YC. (2008). Clinical significance of plasma and serum vascular endothelial growth factor in asthma. J Asthma 45:735–739.
  • Leung TF, Wong GW, Ko FW, Li CY, Yung E, Lam CW, Fok TF. (2005). Analysis of growth factors and inflammatory cytokines in exhaled breath condensate from asthmatic children. Int Arch Allergy Immunol 137:66–72.
  • Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. (2004). Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672–683.
  • Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. (2003). Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649–658.
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. (2005). Standardisation of spirometry. Eur Respir J 26:319–338.
  • Molvarec A, Ito M, Shima T, Yoneda S, Toldi G, Stenczer B, Vásárhelyi B, Rigó J Jr, Saito S. (2010). Decreased proportion of peripheral blood vascular endothelial growth factor-expressing T and natural killer cells in preeclampsia. Am J Obstet Gynecol 203:567.e1–567.e8.
  • NAEPP expert panel report. (2005). Managing asthma during pregnancy: recommendations for pharmacologic treatment – 2004 update. J Allergy Clin Immunol 115:34–46.
  • Palm M, Basu S, Larsson A, Wernroth L, Åkerud H, Axelsson O. (2011). A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy. Acta Obstet Gynecol Scand 90:1244–1251.
  • Park CW, Park JS, Shim SS, Jun JK, Yoon BH, Romero R. (2005). An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia. Am J Obstet Gynecol 193:984–989.
  • Poulin S, Thompson C, Thivierge M, Véronneau S, McMahon S, Dubois CM, Stankova J, Rola-Pleszczynski M. (2011). Cysteinyl-leukotrienes induce vascular endothelial growth factor production in human monocytes and bronchial smooth muscle cells. Clin Exp Allergy 41:204–217.
  • Rodríguez-Trigo G, Zock JP, Pozo-Rodríguez F, Gómez FP, Monyarch G, Bouso L, Coll MD, Verea H, Antó JM, Fuster C, Barberà JA; SEPAR-Prestige Study Group. (2010). Health changes in fishermen 2 years after clean-up of the Prestige oil spill. Ann Intern Med 153:489–498.
  • Schatz M. (1999). Interrelationships between asthma and pregnancy: a literature review. J Allergy Clin Immunol 103:S330–S336.
  • Tamási L, Bohács A, Pállinger E, Falus A, Rigó J Jr, Müller V, Komlósi Z, Magyar P, Losonczy G. (2005). Increased interferon-γ- and interleukin-4-synthesizing subsets of circulating T lymphocytes in pregnant asthmatics. Clin Exp Allergy 35:1197–1203.
  • Tamási L, Bohács A, Bikov A, Andorka C, Rigó J Jr, Losonczy G, Horváth I. (2009). Exhaled nitric oxide in pregnant healthy and asthmatic women. J Asthma 46:786–791.
  • Tamási L, Horváth I, Bohács A, Müller V, Losonczy G, Schatz M. (2011). Asthma in pregnancy – immunological changes and clinical management. Respir Med 105:159–164.
  • Van De Graaf EA, Out TA, Roos CM, Jansen HM. (1991). Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Effects of therapy with inhaled steroids. Am Rev Respir Dis 143:362–368.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.